NCT05417230 2022-06-14RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2Jiangsu Cancer Institute & HospitalPhase 2 Unknown29 enrolled